GlassScriptPhysician profile
Thomas A Dickinson
NPI 1376591354
$3,868.94
in general payments reported to CMS, 2019-2025
24 companies · $26.58 in 2025
The $26.58 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $635 · 2021: $1,741 · 2022: $186 · 2024: $26.34 · 2025: $26.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,264.73 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $482.65 | 2019-2021 | |
| Gilead Sciences, INC. | $279.48 | 2019-2025 | |
| Pfizer INC. | $271.45 | 2019-2021 | |
| Janssen Biotech, INC. | $257.34 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $177.34 | 2021 | |
| Qol Medical, LLC | $140.24 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $124.36 | 2019-2021 | |
| Braintree Laboratories, INC. | $123.71 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $113.24 | 2019-2021 | |
| Allergan, INC. | $112.12 | 2019 | |
| Endo Pharmaceuticals INC. | $90.06 | 2019-2020 | |
| Organon LLC | $67.78 | 2021-2022 | |
| Celgene Corporation | $54.66 | 2021 | |
| Ironwood Pharmaceuticals, INC | $54.20 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $46.80 | 2021 | |
| Romark Laboratories, Lc | $36.02 | 2019-2020 | |
| Shionogi INC | $33.19 | 2019 | |
| Ferring Pharmaceuticals INC. | $28.26 | 2021 | |
| Boston Scientific Corporation | $26.34 | 2024 | |
| Intercept Pharmaceuticals, INC. | $26.03 | 2020 | |
| Daiichi Sankyo INC. | $24.95 | 2021 | |
| Ucb, INC. | $20.04 | 2019 | |
| Janssen Scientific Affairs, LLC | $13.95 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dickinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.